These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5709506)

  • 1. [Tubazid treatment of cavernous pulmonary tuberculosis in the dog].
    Bondarev IM; Zhigalina LI; Novoselova VP
    Probl Tuberk; 1968; 46(7):74-9. PubMed ID: 5709506
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tubazid therapy of cavernous pulmonary tuberculosis in rabbits].
    Bondarev IM; Klebanova AA; Novoselova VP
    Probl Tuberk; 1969; 47(1):77-83. PubMed ID: 5380215
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental substantiation of immunomodulating therapy with sodium nucleinate in tuberculosis].
    Cernuşenko EF; Ciumak AA
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1984; 33(2):143-50. PubMed ID: 6093221
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of the treatment of pulmonary tuberculosis with INAH preparations in different degrees of tubazid inactivation].
    Kagramanov AI; Ezerskiĭ VF; Ezerskaia EN; Kiroshka IZ; Grigorian VG
    Sov Med; 1973 Jul; 36(7):82-4. PubMed ID: 4776714
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of the inactivation of tubazid in the endobronchial method of treatment of destructive pulmonary tuberculosis].
    Kanevskaia SS; Rzhavskov IuV
    Probl Tuberk; 1967; 45(10):44-8. PubMed ID: 5617546
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ethionamide and tubazid in the therapy of pulmonary tuberculosis].
    Pudoĭ NM; Iampol'skaia SA
    Klin Med (Mosk); 1969 Dec; 47(12):74-9. PubMed ID: 5382417
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative data on the tolerance of phthivazid, methazid and tubazid in patients with pulmonary tuberculosis].
    Stepanian ES
    Vrach Delo; 1965 Oct; 10():8-10. PubMed ID: 5896073
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inactivation of tubazid and its influence on the effectiveness of antibacterial therapy of patients with pulmonary tuberculosis].
    Sumbatov GA; Ioffe RA; Poliakova SG
    Probl Tuberk; 1965; 43(8):23-8. PubMed ID: 5869065
    [No Abstract]   [Full Text] [Related]  

  • 9. [One-year results of initial therapy of cavernous pulmonary tuberculosis with isoniazid, streptomycin and ethionamide].
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Gruzlica; 1965 Jul; 33(7):565-70. PubMed ID: 5849562
    [No Abstract]   [Full Text] [Related]  

  • 10. [The hazards of intravenous infusions of tubazid].
    Gubanova GF
    Klin Med (Mosk); 1972 Sep; 50(9):129-31. PubMed ID: 4652956
    [No Abstract]   [Full Text] [Related]  

  • 11. [Resuscitation in acute tubazid poisoning].
    Mukhin EP; Klimova TP; Uzbekova AA
    Klin Med (Mosk); 1974 Jan; 52(1):137-9. PubMed ID: 4466878
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of pyrogens in the complex treatment of pulmonary tuberculosis].
    Ianchenko EN
    Probl Tuberk; 1971; 49(12):29-33. PubMed ID: 5159684
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pyrogens in the complex treatment of pulmonary tuberculosis].
    Ianchenko EN
    Vrach Delo; 1972 Oct; 10():85-8. PubMed ID: 4658420
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of acute poisoning with tubazid].
    Kolotovkin PS
    Probl Tuberk; 1967; 45(4):83-4. PubMed ID: 5605431
    [No Abstract]   [Full Text] [Related]  

  • 15. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of individual phasic analyses of ventricular systoles based on rheographic data in evaluating the effect of tubazid on the myocardium].
    Nakhutin LS; Khatenever NL; Vulikh MIa
    Probl Tuberk; 1972; 50(11):39-42. PubMed ID: 4647616
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of patients with pulmonary tuberculosis with the use of differentiated single doses of Tubazid].
    Smirnov GA; Abdullina ZR
    Probl Tuberk; 1970; 48(9):24-9. PubMed ID: 5518270
    [No Abstract]   [Full Text] [Related]  

  • 18. [Express method of intravenous administration of tubazid].
    Bondarev IM; Sokolova GB
    Probl Tuberk; 1973; 51(10):19-24. PubMed ID: 4784032
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of one-year chemotherapy in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Janczy S; Buraczewska M; Korlakowski J; Zych D; Krychniak W
    Pol Med J; 1966; 5(3):526-32. PubMed ID: 5920266
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of pyrogens on nonspecific reactivity in patients with pulmonary tuberculosis].
    Ianchenko EN
    Probl Tuberk; 1969; 47(4):32-6. PubMed ID: 5368441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.